Cargando…

Mind the treatment gap: the prevalence of common mental disorder symptoms, risky substance use and service utilization among young Swiss adults

BACKGROUND: Common mental disorders (CMDs) are highly prevalent and contribute significantly to the global burden of disease, yet there is evidence of a large treatment gap. We aimed to quantify this gap among young adults with symptoms of CMDs and examine the relationship between substance use and...

Descripción completa

Detalles Bibliográficos
Autores principales: Werlen, Laura, Puhan, Milo A., Landolt, Markus A., Mohler-Kuo, Meichun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526325/
https://www.ncbi.nlm.nih.gov/pubmed/32993605
http://dx.doi.org/10.1186/s12889-020-09577-6
_version_ 1783588851219955712
author Werlen, Laura
Puhan, Milo A.
Landolt, Markus A.
Mohler-Kuo, Meichun
author_facet Werlen, Laura
Puhan, Milo A.
Landolt, Markus A.
Mohler-Kuo, Meichun
author_sort Werlen, Laura
collection PubMed
description BACKGROUND: Common mental disorders (CMDs) are highly prevalent and contribute significantly to the global burden of disease, yet there is evidence of a large treatment gap. We aimed to quantify this gap among young adults with symptoms of CMDs and examine the relationship between substance use and perceived need for care and mental health service utilization. METHODS: In a nationally representative, cross-sectional survey of young Swiss adults’ mental health and wellbeing, we assessed symptoms of anxiety, depression, and attention deficit hyperactivity disorder (ADHD) with widely used screening instruments and asked about participant suicidal ideation, suicide attempts, mental health-related quality of life, alcohol and drug use, perceived need for mental health care, and mental health service utilization. We used these variables to calculate the treatment gap and weighted all analyses according to the stratified sampling plan. RESULTS: Around a quarter of young adults screened positive for at least one CMD. Participants who screened positive for anxiety and/or depression reported significantly more suicidal ideation and lifetime suicide attempts and reported worse mental health-related quality of life than participants who did not screen positive for a disorder. Women’s prevalence of anxiety and depression symptoms was significantly higher than men’s, while men were more likely to report most types of risky drug use. Among those with a CMD, only around half perceived lifetime need for care, and less than 20% reported currently utilizing mental health services. Young adults with a CMD reporting risky weekly use of alcohol were less likely to be currently using services. CONCLUSION: The high prevalence of CMD symptoms could reflect a rising prevalence of these disorders mirroring increasing trends observed in other countries. To address the large treatment gap, interventions promoting mental health literacy and more research on additional barriers to inform further interventions are needed.
format Online
Article
Text
id pubmed-7526325
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-75263252020-10-01 Mind the treatment gap: the prevalence of common mental disorder symptoms, risky substance use and service utilization among young Swiss adults Werlen, Laura Puhan, Milo A. Landolt, Markus A. Mohler-Kuo, Meichun BMC Public Health Research Article BACKGROUND: Common mental disorders (CMDs) are highly prevalent and contribute significantly to the global burden of disease, yet there is evidence of a large treatment gap. We aimed to quantify this gap among young adults with symptoms of CMDs and examine the relationship between substance use and perceived need for care and mental health service utilization. METHODS: In a nationally representative, cross-sectional survey of young Swiss adults’ mental health and wellbeing, we assessed symptoms of anxiety, depression, and attention deficit hyperactivity disorder (ADHD) with widely used screening instruments and asked about participant suicidal ideation, suicide attempts, mental health-related quality of life, alcohol and drug use, perceived need for mental health care, and mental health service utilization. We used these variables to calculate the treatment gap and weighted all analyses according to the stratified sampling plan. RESULTS: Around a quarter of young adults screened positive for at least one CMD. Participants who screened positive for anxiety and/or depression reported significantly more suicidal ideation and lifetime suicide attempts and reported worse mental health-related quality of life than participants who did not screen positive for a disorder. Women’s prevalence of anxiety and depression symptoms was significantly higher than men’s, while men were more likely to report most types of risky drug use. Among those with a CMD, only around half perceived lifetime need for care, and less than 20% reported currently utilizing mental health services. Young adults with a CMD reporting risky weekly use of alcohol were less likely to be currently using services. CONCLUSION: The high prevalence of CMD symptoms could reflect a rising prevalence of these disorders mirroring increasing trends observed in other countries. To address the large treatment gap, interventions promoting mental health literacy and more research on additional barriers to inform further interventions are needed. BioMed Central 2020-09-29 /pmc/articles/PMC7526325/ /pubmed/32993605 http://dx.doi.org/10.1186/s12889-020-09577-6 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Werlen, Laura
Puhan, Milo A.
Landolt, Markus A.
Mohler-Kuo, Meichun
Mind the treatment gap: the prevalence of common mental disorder symptoms, risky substance use and service utilization among young Swiss adults
title Mind the treatment gap: the prevalence of common mental disorder symptoms, risky substance use and service utilization among young Swiss adults
title_full Mind the treatment gap: the prevalence of common mental disorder symptoms, risky substance use and service utilization among young Swiss adults
title_fullStr Mind the treatment gap: the prevalence of common mental disorder symptoms, risky substance use and service utilization among young Swiss adults
title_full_unstemmed Mind the treatment gap: the prevalence of common mental disorder symptoms, risky substance use and service utilization among young Swiss adults
title_short Mind the treatment gap: the prevalence of common mental disorder symptoms, risky substance use and service utilization among young Swiss adults
title_sort mind the treatment gap: the prevalence of common mental disorder symptoms, risky substance use and service utilization among young swiss adults
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526325/
https://www.ncbi.nlm.nih.gov/pubmed/32993605
http://dx.doi.org/10.1186/s12889-020-09577-6
work_keys_str_mv AT werlenlaura mindthetreatmentgaptheprevalenceofcommonmentaldisordersymptomsriskysubstanceuseandserviceutilizationamongyoungswissadults
AT puhanmiloa mindthetreatmentgaptheprevalenceofcommonmentaldisordersymptomsriskysubstanceuseandserviceutilizationamongyoungswissadults
AT landoltmarkusa mindthetreatmentgaptheprevalenceofcommonmentaldisordersymptomsriskysubstanceuseandserviceutilizationamongyoungswissadults
AT mohlerkuomeichun mindthetreatmentgaptheprevalenceofcommonmentaldisordersymptomsriskysubstanceuseandserviceutilizationamongyoungswissadults